4.7 Review

When less is more: the forbidden fruits of gene repression in the adult β-cell

期刊

DIABETES OBESITY & METABOLISM
卷 15, 期 6, 页码 503-512

出版社

WILEY
DOI: 10.1111/dom.12029

关键词

gene profile; insulin secretion; type 2 diabetes; beta-cell

资金

  1. Wellcome Trust Programme [081958/Z/07/Z]
  2. WellcomeTrust Senior Investigator [WT098424AIA]
  3. Royal Society Wolfson Research Merit Award

向作者/读者索取更多资源

Outside of the biological arena the term repression' often has a negative connotation. However, in the pancreatic -cell a small group of genes, which are abundantly expressed in most if not all other mammalian tissues, are highly selectively repressed, with likely functional consequences. The two founder' members of this group, lactate dehydrogenase A (Ldha) and monocarboxylate transporter-1 (MCT-1/Slc16a1), are inactivated by multiple mechanisms including histone modifications and microRNA-mediated silencing. Their inactivation ensures that pyruvate and lactate, derived from muscle during exercise, do not stimulate insulin release inappropriately. Correspondingly, activating mutations in the MCT-1 promoter underlie exercise-induced hyperinsulinism' (EIHI) in man, a condition mimicked by forced over-expression of MCT-1 in the -cell in mice. Furthermore, LDHA expression in the -cell is upregulated in both human type 2 diabetes and in rodent models of the disease. Recent work by us and by others has identified a further approximate to 60 genes which are selectively inactivated in the -cell, a list which we refine here up to seven by detailed comparison of the two studies. These genes include key regulators of cell proliferation and stimulus-secretion coupling. The present, and our earlier results, thus highlight the probable importance of shutting down a subset of disallowed' genes for the differentiated function of -cells, and implicate previously unsuspected signalling pathways in the control of -cell expansion and insulin secretion. Targeting of deregulated disallowed' genes in these cells may thus, in the future, provide new therapeutic avenues for type 2 diabetes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据